These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
329 related articles for article (PubMed ID: 31935836)
1. Mesenchymal Stromal Cells from Fetal and Maternal Placenta Possess Key Similarities and Differences: Potential Implications for Their Applications in Regenerative Medicine. Papait A; Vertua E; Magatti M; Ceccariglia S; De Munari S; Silini AR; Sheleg M; Ofir R; Parolini O Cells; 2020 Jan; 9(1):. PubMed ID: 31935836 [TBL] [Abstract][Full Text] [Related]
2. Placenta-Derived Adherent Stromal Cell Therapy for Hematopoietic Disorders: A Case Study of PLX-R18. Sher N; Ofir R Cell Transplant; 2018 Jan; 27(1):140-150. PubMed ID: 29562777 [TBL] [Abstract][Full Text] [Related]
3. Expression of Desmoglein 2, Desmocollin 3 and Plakophilin 2 in Placenta and Bone Marrow-Derived Mesenchymal Stromal Cells. Hart ML; Rusch E; Kaupp M; Nieselt K; Aicher WK Stem Cell Rev Rep; 2017 Apr; 13(2):258-266. PubMed ID: 28154962 [TBL] [Abstract][Full Text] [Related]
4. Chorion Mesenchymal Stem Cells Show Superior Differentiation, Immunosuppressive, and Angiogenic Potentials in Comparison With Haploidentical Maternal Placental Cells. González PL; Carvajal C; Cuenca J; Alcayaga-Miranda F; Figueroa FE; Bartolucci J; Salazar-Aravena L; Khoury M Stem Cells Transl Med; 2015 Oct; 4(10):1109-21. PubMed ID: 26273064 [TBL] [Abstract][Full Text] [Related]
5. Avoidance of Maternal Cell Contamination and Overgrowth in Isolating Fetal Chorionic Villi Mesenchymal Stem Cells from Human Term Placenta. Sardesai VS; Shafiee A; Fisk NM; Pelekanos RA Stem Cells Transl Med; 2017 Apr; 6(4):1070-1084. PubMed ID: 28205414 [TBL] [Abstract][Full Text] [Related]
6. The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia. Prather WR; Toren A; Meiron M; Ofir R; Tschope C; Horwitz EM Cytotherapy; 2009; 11(4):427-34. PubMed ID: 19526389 [TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory placental-expanded, mesenchymal stromal cells improve muscle function following hip arthroplasty. Winkler T; Perka C; von Roth P; Agres AN; Plage H; Preininger B; Pumberger M; Geissler S; Hagai EL; Ofir R; Pinzur L; Eyal E; Stoltenburg-Didinger G; Meisel C; Consentius C; Streitz M; Reinke P; Duda GN; Volk HD J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):880-897. PubMed ID: 30230266 [TBL] [Abstract][Full Text] [Related]
8. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. In 't Anker PS; Scherjon SA; Kleijburg-van der Keur C; de Groot-Swings GM; Claas FH; Fibbe WE; Kanhai HH Stem Cells; 2004; 22(7):1338-45. PubMed ID: 15579651 [TBL] [Abstract][Full Text] [Related]
9. Influence of culture media on the derivation and phenotype of fetal-derived placental mesenchymal stem/stromal cells across gestation. Boss AL; Brooks AES; Chamley LW; James JL Placenta; 2020 Nov; 101():66-74. PubMed ID: 32932101 [TBL] [Abstract][Full Text] [Related]
11. Comparative phenotypic transcriptional characterization of human full-term placenta-derived mesenchymal stromal cells compared to bone marrow-derived mesenchymal stromal cells after differentiation in myogenic medium. Hart ML; Kaupp M; Brun J; Aicher WK Placenta; 2017 Jan; 49():64-67. PubMed ID: 28012456 [TBL] [Abstract][Full Text] [Related]
12. B Lymphocytes as Targets of the Immunomodulatory Properties of Human Amniotic Mesenchymal Stromal Cells. Magatti M; Masserdotti A; Bonassi Signoroni P; Vertua E; Stefani FR; Silini AR; Parolini O Front Immunol; 2020; 11():1156. PubMed ID: 32582218 [TBL] [Abstract][Full Text] [Related]
13. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells. Miao Z; Jin J; Chen L; Zhu J; Huang W; Zhao J; Qian H; Zhang X Cell Biol Int; 2006 Sep; 30(9):681-7. PubMed ID: 16870478 [TBL] [Abstract][Full Text] [Related]
14. Stem cells isolated from the human stromal limbus possess immunosuppressant properties. Garfias Y; Nieves-Hernandez J; Garcia-Mejia M; Estrada-Reyes C; Jimenez-Martinez MC Mol Vis; 2012; 18():2087-95. PubMed ID: 22876135 [TBL] [Abstract][Full Text] [Related]
15. Comparison of the Biological Characteristics of Mesenchymal Stem Cells Derived from the Human Placenta and Umbilical Cord. Wu M; Zhang R; Zou Q; Chen Y; Zhou M; Li X; Ran R; Chen Q Sci Rep; 2018 Mar; 8(1):5014. PubMed ID: 29568084 [TBL] [Abstract][Full Text] [Related]
16. Comparison of feto-maternal organ derived stem cells in facets of immunophenotype, proliferation and differentiation. Indumathi S; Harikrishnan R; Mishra R; Rajkumar JS; Padmapriya V; Lissa RP; Dhanasekaran M Tissue Cell; 2013 Dec; 45(6):434-42. PubMed ID: 24008115 [TBL] [Abstract][Full Text] [Related]
17. Allogenic Use of Human Placenta-Derived Stromal Cells as a Highly Active Subtype of Mesenchymal Stromal Cells for Cell-Based Therapies. Gorodetsky R; Aicher WK Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069909 [TBL] [Abstract][Full Text] [Related]
18. Establishment and characterization of fetal and maternal mesenchymal stem/stromal cell lines from the human term placenta. Qin SQ; Kusuma GD; Al-Sowayan B; Pace RA; Isenmann S; Pertile MD; Gronthos S; Abumaree MH; Brennecke SP; Kalionis B Placenta; 2016 Mar; 39():134-46. PubMed ID: 26992686 [TBL] [Abstract][Full Text] [Related]
19. Comparison of immune modulatory properties of human multipotent mesenchymal stromal cells derived from bone marrow and placenta. Sarıkaya A; Aydın G; Özyüncü Ö; Şahin E; Uçkan-Çetinkaya D; Aerts-Kaya F Biotech Histochem; 2022 Feb; 97(2):79-89. PubMed ID: 33641543 [TBL] [Abstract][Full Text] [Related]
20. Mesenchymal Stromal Cells Prevent Allostimulation In Vivo and Control Checkpoints of Th1 Priming: Migration of Human DC to Lymph Nodes and NK Cell Activation. Consentius C; Akyüz L; Schmidt-Lucke JA; Tschöpe C; Pinzur L; Ofir R; Reinke P; Volk HD; Juelke K Stem Cells; 2015 Oct; 33(10):3087-99. PubMed ID: 26184374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]